Rose Charles E, Romero-Steiner Sandra, Burton Robert L, Carlone George M, Goldblatt David, Nahm Moon H, Ashton Lindsey, Haston Mitch, Ekström Nina, Haikala Raili, Käyhty Helena, Henckaerts Isabelle, Durant Nathalie, Poolman Jan T, Fernsten Phil, Yu Xinhong, Hu Branda T, Jansen Kathrin U, Blake Milan, Simonetti Elles R, Hermans Peter W M, Plikaytis Brian D
Biostatistics Office, DBD, Centers for Disease Control and Prevention, Building 1, Room 5044, MS C-09, 1600 Clifton Road, Atlanta, GA 30333, USA.
Clin Vaccine Immunol. 2011 Jan;18(1):135-42. doi: 10.1128/CVI.00370-10. Epub 2010 Nov 17.
Antibody-mediated killing of Streptococcus pneumoniae (pneumococcus) by phagocytes is an important mechanism of protection of the human host against pneumococcal infections. Measurement of opsonophagocytic antibodies by use of a standardized opsonophagocytic assay (OPA) is important for the evaluation of candidate vaccines and required for the licensure of new pneumococcal conjugate vaccine formulations. We assessed agreement among six laboratories that used their own optimized OPAs on a panel of 16 human reference sera for 13 pneumococcal serotypes. Consensus titers, estimated using an analysis-of-variance (ANOVA) mixed-effects model, provided a common reference for assessing agreement among these laboratories. Agreement was evaluated in terms of assay accuracy, reproducibility, repeatability, precision, and bias. We also reviewed four acceptance criterion intervals for assessing the comparability of protocols when assaying the same reference sera. The precision, accuracy, and concordance results among laboratories and the consensus titers revealed acceptable agreement. The results of this study indicate that the bioassays evaluated in this study are robust, and the resultant OPA values are reproducible for the determination of functional antibody titers specific to 13 pneumococcal serotypes when performed by laboratories using highly standardized but not identical assays. The statistical methodologies employed in this study may serve as a template for evaluating future multilaboratory studies.
吞噬细胞通过抗体介导杀灭肺炎链球菌是人类宿主抵御肺炎球菌感染的重要保护机制。使用标准化的吞噬细胞杀菌试验(OPA)检测调理吞噬抗体对于评估候选疫苗很重要,也是新型肺炎球菌结合疫苗配方获批所必需的。我们评估了六个实验室之间的一致性,这些实验室在一组针对13种肺炎球菌血清型的16份人类参考血清上使用了各自优化的OPA。使用方差分析(ANOVA)混合效应模型估计的共识滴度为评估这些实验室之间的一致性提供了共同参考。从检测准确性、可重复性、重复性、精密度和偏差方面评估一致性。我们还审查了四个验收标准区间,用于评估检测相同参考血清时方案的可比性。实验室之间的精密度、准确性和一致性结果以及共识滴度显示出可接受的一致性。本研究结果表明,本研究中评估的生物测定方法是可靠的,当实验室使用高度标准化但不完全相同的测定方法进行检测时,所得的OPA值对于确定13种肺炎球菌血清型特异性的功能性抗体滴度具有可重复性。本研究中采用的统计方法可作为评估未来多实验室研究的模板。